This summer, Norton Healthcare hopes to launch a new islet cell program to help treat chronic pancreatitis and eventually ...
Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked the first large, outpatient, randomised, controlled trial to show a ...
Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound® (tirzepatide) to include the four-dose single-patient use KwikPen® that ...
The latest wellness craze involves injecting these molecules for athletic performance, longevity and more. Scientists say the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results